U.S. market Open. Closes in 58 minutes

CVM | CEL-SCI Corporation Stock Overview

(Stock Exchange: AMEX)
Day's Range 0.7001 - 0.7446
52 Week Range 0.6800 - 3.23
Beta 0.58
Implied Volatility 362.84%
IV Rank 94.94%
Day's Volume 578,511
Average Volume 303,754
Shares Outstanding 63,807,100
Market Cap 46,279,290
Sector Healthcare
Industry Biotechnology
IPO Date 1983-12-08
Valuation
Profitability
Growth
Health
P/E Ratio -1.37
Forward P/E Ratio N/A
EPS -0.53
1YR Price Target N/A
Dividend Yield N/A
Dividend Per Share N/A
Dividend ExDate N/A
Dividend PayDate N/A
Employees 43
Country USA
Website CVM
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and cancer. The company also develops LEAPS-H1N1-DC; CEL-2000 and CEL-4000 are product candidates for the treatment of rheumatoid arthritis; and LEAPS COV-19, a product candidate to treat COVID-19 coronavirus. CEL-SCI Corporation has a collaboration agreement with the University of Georgia's Center for Vaccines and Immunology to develop LEAPS COVID-19 immunotherapy. The company was incorporated in 1983 and is headquartered in Vienna, Virginia.
CVM's peers: CTIC, AGEN, AEZS, CYCC, BCRX
*Chart delayed
Analyzing fundamentals for CVM we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is frighteningly weak. For more detailed analysis please see CVM Fundamentals page.

Watching at CVM technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on CVM Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙